BGB-23339 / BeiGene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BGB-23339 / BeiGene
BGB-23339-101, NCT05093270: First-in-Human, Single- and Multiple-Ascending Dose and Food-Effect Study of BGB-23339 in Healthy Participants

Completed
1
92
RoW
BGB-23339, Placebo
BeiGene
Not Determined
09/22
12/22
BGB-23339-102, NCT05387668: Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

Withdrawn
1
0
US
BGB-23339, Placebo
BeiGene
Healthy Volunteers
10/22
10/22

Download Options